Table 1.
Authors name | Region | Country | Diagnostic criteria | Types of DM | Study design | Age of subjects | Sample size | No of people with outcome | Prevalence (%) |
---|---|---|---|---|---|---|---|---|---|
Rahlenbech [43] | Eastern Africa | Ethiopia | Microalbuminuria | Both types | Cross-sectional | ≥ 18 | 170 | 55 | 32.35 |
Sobngwi et al. [44] | Central Africa | Cameroon | Microalbuminuria | Both types | Cross-sectional | ≥ 18 | 64 | 34 | 53.13 |
Motala et al. [45] | Southern Africa | South Africa | Proteinuria | Both types | Cross-sectional | All | 219 | 54 | 24.66 |
Wanjohi et al. [46] | Eastern Africa | Kenya | Albuminuria | Type 2 | Cross-sectional | ≥ 18 | 100 | 26 | 26.00 |
Rotchford and Rotchford [31] | Southern Africa | South Africa | Microalbuminuria | Both types | Cross-sectional | ≥ 18 | 254 | 102 | 40.16 |
Albiosu [47] | Western Africa | Nigeria | Microalbuminuria | Both types | Cross-sectional | ≥ 18 | 342 | 97 | 28.36 |
Alebiosu et al. [48] | Western Africa | Nigeria | Any sign | Both types | Cross-sectional | Not report | 465 | 191 | 41.08 |
Agaba et al. [49] | Western Africa | Nigeria | Microalbuminuria | Type-2 | Cross-sectional | ≥ 18 | 65 | 32 | 49.23 |
Mafundikwa et al. [50] | Eastern Africa | Zimbabwe | Proteinuria | Type-2 | Cross-sectional | ≥ 18 | 75 | 16 | 21.33 |
Lutale et al. [51] | Eastern Africa | Tanzania | Microalbuminuria | Both types | Cross-sectional | All age | 244 | 26 | 10.66 |
Majaliiwa et al. [52] | Eastern Africa | Tanzania | Microalbuminuria | Type-1 | Cross-sectional | < 18 | 99 | 29 | 29.29 |
Rahamtalla et al. [53] | Eastern Africa | Sudan | Nephropathy | Type-2 | Cross-sectional | ≥ 18 | 58 | 26 | 44.83 |
Rasmussen et al. [54] | Eastern Africa | Zambia | Microalbuminuria | Not-report | Cross-sectional | < 18 | 193 | 24 | 12.44 |
Tamba et al. [55] | Central Africa | Cameroon | Nephropathy | Type-2 | Cross-sectional | ≥ 18 | 140 | 35 | 25.00 |
Janmohamed et al. [56] | Eastern Africa | Tanzania | eGFR | Both types | Cross-sectional | ≥ 18 | 369 | 308 | 83.47 |
Ajayi et al. [57] | Western Africa | Nigeria | eGFR | Type 2 | Cross-sectional | ≥ 18 | 628 | 242 | 38.54 |
Deribe et al. [58] | Eastern Africa | Ethiopia | eGFR | Not report | Cross-sectional | ≥ 18 | 216 | 19 | 8.80 |
Fiseha et al. [59] | Eastern Africa | Ethiopia | eGFR | Both types | Cross-sectional | ≥ 18 | 214 | 51 | 23.83 |
Bunza et al. [60] | Western Africa | Nigeria | Nephropathy | Both types | Cross-sectional | ≥ 18 | 100 | 22 | 22.00 |
Ngassa et al. [61] | Southern Africa | South Africa | Microalbuminuria | Both types | Cross-sectional | ≥ 18 | 754 | 251 | 33.29 |
Diouf et al. [62] | Western Africa | Senegal | Microalbuminuria | Type-2 | Cross-sectional | ≥ 18 | 195 | 95 | 48.72 |
Chukwuani et al. [63] | Western Africa | Nigeria | Microalbuminuria | Type-2 | Cross-sectional | ≥ 18 | 200 | 76 | 38.00 |
Bekele [64] | Eastern Africa | Ethiopia | Nephropathy | Both types | Cross-sectional | ≥ 18 | 355 | 68 | 19.15 |
Ufuoma et al. [65] | Western Africa | Nigeria | Microalbuminuria | Type-2 | Cross-sectional | ≥ 18 | 200 | 116 | 58.00 |
Machinngura et al. [66] | Eastern Africa | Zimbabwe | Nephropathy | Both types | Cross-sectional | ≥ 18 | 344 | 154 | 44.77 |
Radikara [67] | Southern Africa | Botswana | Nephropathy | Type-2 | Cross-sectional | ≥ 18 | 408 | 259 | 63.48 |
Marie et al. [30] | Central Africa | Cameroon | Microalbuminuria | Not report | Cross-sectional | ≥ 18 | 81 | 28 | 34.57 |